SuperworthAbbVie profit margin ABBV
Gross, operating and net profit as a share of revenue over the last twelve months, from 2012.
- Net margin, 12 months
- 9.8%
- Operating margin, 12 months
- 26.2%
- Net margin on a year earlier
- +3.3 pts
- Peer median
- 12.8%
Over the twelve months to Jun 30, 2026, AbbVie kept 9.8% of its revenue as net profit, with an operating margin of 26.2% and a gross margin of 71.5%.
Five years earlier its net margin was 12.4%.
The median for 7 large drugmakers of a similar size is 12.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 6.9% | 24.6% | 70.2% |
| FY2024 | 7.6% | 16.2% | 70.0% |
| FY2023 | 9.0% | 23.5% | 62.4% |
| FY2022 | 20.4% | 31.2% | 70.0% |
| FY2021 | 20.5% | 31.9% | 69.0% |
| FY2020 | 10.1% | 24.8% | 66.4% |
| FY2019 | 23.7% | 39.0% | 77.6% |
| FY2018 | 17.4% | 19.5% | 76.4% |
| FY2017 | 18.8% | 33.8% | 75.0% |
| FY2016 | 23.2% | 36.6% | 77.2% |
| FY2015 | 22.5% | 33.0% | 80.3% |
| FY2014 | 8.9% | 17.1% | 77.8% |
| FY2013 | 22.0% | 30.1% | 75.6% |
| FY2012 | 28.7% | 31.6% | 75.5% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 9.8% | +3.3 pts | 26.2% | |
| Q1 FY26 | 5.8% | −1.5 pts | 24.4% | |
| Q4 FY25 | 6.9% | −0.7 pts | 24.6% | |
| Q3 FY25 | 4.0% | −5.2 pts | 15.2% | |
| Q2 FY25 | 6.5% | −3.3 pts | 18.8% | |
| Q1 FY25 | 7.3% | −3.7 pts | 17.6% | |
| Q4 FY24 | 7.6% | −1.4 pts | 16.2% | |
| Q3 FY24 | 9.2% | −2.6 pts | 24.9% | |
| Q2 FY24 | 9.7% | −5.8 pts | 22.3% | |
| Q1 FY24 | 11.0% | −2.4 pts | 23.5% | |
| Q4 FY23 | 9.0% | −11.4 pts | 23.5% | |
| Q3 FY23 | 11.8% | −11.4 pts | 27.3% |
Against its peers
Companies in Drug Manufacturers - General nearest AbbVie's size, closest first, today.
| Company | Profit margin |
|---|---|
| ABBVAbbVie | 9.8% |
| JNJJohnson & Johnson | n/m |
| MRKMerck | 4.8% |
| AMGNAmgen | 23.0% |
| LLYEli Lilly and | 33.5% |
| GILDGilead Sciences | −10.6% |
| PFEPfizer | 6.8% |
| BMYBristol-Myers Squibb | 18.9% |
| Peer median | 12.8% |
Where AbbVie ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on AbbVie
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.